Agentic AI in Medicare Needs a Trust Layer Before It Gets Scale

Centers for Medicare & Medicaid Services leaders are talking openly about agentic artificial intelligence for Medicare beneficiaries. That may sound like a technology story, but the real issue is trust. In Medicare, a polished answer is not enough. If artificial intelligence is going to help people compare plans, choose doctors, or understand coverage, it needs current data, clear limits, and a simple path to a human when things get complicated.

Farzin Espahani

Strategic Advisor, Insurance Growth, Medicare Distribution, and Compliance

When Centers for Medicare & Medicaid Services (CMS) leaders talk about agentic artificial intelligence (AI) for Medicare beneficiaries, the first reaction is often about speed and convenience. Could AI help people compare Medicare Advantage (MA) plans, find doctors, answer coverage questions, or get support after hours?

It probably can.

That is not the hard part.

The harder question is whether Medicare beneficiaries will trust it when the choice actually matters. In this market, a smooth answer is not enough. People are making decisions that affect access, cost, provider relationships, and care timing. If the answer is wrong, the damage does not stay digital. It shows up in bad enrollments, confused members, call center volume, provider abrasion, and avoidable rework.

That is why this moment deserves more than a "healthcare AI is coming" reaction. For payers, providers, and technology teams, the signal from Washington is really about something deeper. The next phase of AI in healthcare will be judged less by what it can say and more by what the system behind it can prove.

What Is Changing

According to Inside Health Policy reporting from March 12, 2026, CMS Administrator Mehmet Oz said the administration wants all Medicare beneficiaries to have access to agentic AI tools by the end of its term. He pointed to practical use cases such as helping beneficiaries choose MA plans and doctors.

That is a meaningful shift in tone.

For years, much of the healthcare AI conversation has lived inside the enterprise. Documentation support. Call routing. Workflow help. Utilization review. Analytics. Internal productivity. Those use cases still matter, but beneficiary-facing AI is a different category. Once the technology starts shaping consumer decisions, the standards need to change.

A beneficiary asking "Which plan fits my medications and doctors?" is not the same as a team using AI to summarize notes. One affects a life decision. The other supports an internal process.

Healthcare tends to underestimate that gap.

Why Trust Is the Real Issue

Oz also acknowledged the central barrier. Beneficiaries do not automatically trust AI.

That should not surprise anyone who works in this space.

Medicare is already full of friction. Plan comparisons can be confusing. Provider directories are not always current. Drug coverage is hard to explain in plain language. Prior authorization is frustrating. Out-of-pocket costs are often not fully understood until after care is delivered. If AI enters that environment without stronger controls, it will not reduce confusion. It will scale it.

Trust in this context is not a marketing problem. It is an operating problem.

People do not trust healthcare tools because they sound smart. They trust them when the data is current, the logic is explainable, the limits are obvious, and the handoff to a human is easy when the issue gets messy.

That last point matters. A beneficiary should never have to guess whether they are getting education, service guidance, or something that sounds like clinical advice. The system should make that line clear.

Where the Real Risk Sits

The biggest mistake organizations can make is treating this as a front-end project.

A lot of teams will focus on the assistant itself. Better prompts. Better design. Better voice. Better response speed.

That work matters, but it is not where trust is won.

Trust is won underneath the interface. It lives in provider directory quality, formulary accuracy, plan rule mapping, audit trails, disclosure logic, escalation workflows, permissions, update cadence, and governance. In other words, the trust layer.

Without that layer, the tool may still look polished. It may even test well in short demos. But once it meets real member behavior, real provider variation, and real edge cases, the cracks show fast.

In Medicare, those cracks get expensive.

What Health Plans Should Do Now

Health plans should look at this moment with both ambition and restraint.

The ambition is easy to see. A good AI support layer could reduce avoidable call volume, help members sort through plan tradeoffs, improve understanding during enrollment, and create better support outside normal service windows. It could also reduce some of the confusion that drives complaints and downstream dissatisfaction.

Still, health plans should resist the urge to launch something consumer-facing before the underlying controls are ready.

The right questions are basic.

• Can the system show where the answer came from?
• Can it tell the user when the data was last refreshed?
• Can it separate general education from recommendation?
• Can it flag uncertainty instead of hiding it?
• Can it move the beneficiary to a licensed agent, service representative, nurse, or care guide with minimal friction?

If the answer to those questions is weak, the launch is early.

What Providers and Care Teams Should Watch

Providers should not assume this is only a payer story.

If beneficiaries begin using AI tools to find doctors, understand access, ask follow-up care questions, or sort through coverage choices, providers will feel the operational effects. Scheduling pressure can shift. Support burden can shift. Patient expectations can shift. So can frustration, especially if the digital answer does not match real-world availability or workflow.

That is why patient-facing AI and provider operations cannot sit in separate lanes for long. If a system tells patients one thing and the local care environment says another, staff will end up cleaning up the gap.

A useful tool should reduce mismatch, not create a new version of it.

What Vendors Need to Prove

This market does not need another healthcare assistant that performs well in a conference demo and weakly in production.

Vendors need to prove that the system is dependable under regulated, high-friction conditions.

That means five things matter more than the interface alone.

1. The data is current.
2. The logic is traceable.
3. The system keeps a record of what was shown and disclosed.
4. Human backup is easy to reach.
5. Success is measured by downstream quality, not just engagement.

That final point is where a lot of programs drift off course. If teams judge success by session length, completion rate, or call deflection alone, they can end up rewarding the wrong behavior. In Medicare, stronger measures include better plan fit, fewer complaints, cleaner enrollments, lower rework, and a better member experience after the digital interaction ends.

Those are the signals that tell you whether the tool is actually helping.

What Good Looks Like

A useful Medicare AI experience should feel less like a chatbot and more like guided decision support.

• It should speak plainly.
• It should show tradeoffs.
• It should say when it is unsure.
• It should make human help easy to reach.
• It should leave a clear record for compliance, operations, and quality review.

Most of all, it should lower stress for the beneficiary.

That is the part the market should not lose sight of. The goal is not to make Medicare feel more automated. The goal is to make it easier for people to make sound choices in a system that often feels too hard to navigate.

If CMS pushes this category forward, the winners will not be the teams with the flashiest AI story. They will be the teams that build a trust layer strong enough to carry real beneficiary decisions.

In Medicare, better controls still beat better demos.

Farzin Espahani

Principal Consultant, VHealth

Farzin Espahani is a Strategic Advisor focused on insurance growth, Medicare distribution, healthcare operations, and compliance-aware performance marketing.

He has led growth, marketplace operations, partner distribution, and Medicare marketing initiatives across regulated healthcare and insurance markets, with experience spanning QuinStreet, Health IQ, Solution21, and The Patient's Guide, which was acquired by IAC Publishing.

At QuinStreet, he worked across Medicare and health insurance distribution, performance marketing, partner economics, lead quality, compliance alignment, funnel performance, and AI-enabled consumer decision support, including the development of an AI-powered Medicare plan recommendation experience for Insure.com.

Farzin also serves in industry leadership and advisory roles with the Insurance Marketing Coalition and Lead Quality Alliance, where his work supports ethical marketing, lead quality, consumer transparency, and compliance-aware growth.

His academic background in biocultural anthropology, sociology, and social psychology informs how he evaluates consumer behavior, incentives, trust, decision-making, and organizational friction. His executive education includes programs at Massachusetts Institute of Technology (MIT) Sloan, Wharton, Cornell, and Northwestern Kellogg, with advanced study in artificial intelligence (AI), revenue analytics, pricing, leadership, change management, and communication.

For VHealth, Farzin brings a practical advisory lens on healthcare growth, workflow visibility, regulated distribution, compliance-aware interpretation, and responsible AI-enabled decision support.